Summary:
In patients with polycystic ovary syndrome (PCOS), Salvia officinalis extract significantly reduced triglyceride levels and oxidative stress markers compared to placebo, though it was associated with no significant changes in other lipid profile markers.
| PICO | Description |
|---|---|
| Population | Patients diagnosed with polycystic ovary syndrome (PCOS). |
| Intervention | Salvia officinalis extract (dosages as prescribed by study protocol). |
| Comparison | Placebo capsules administered to the control group. |
| Outcome | Salvia officinalis extract significantly decreased triglyceride levels and oxidative stress markers. However, no significant changes in other lipid profile markers were observed. These findings suggest its potential as an adjunctive therapy for metabolic and oxidative imbalances in PCOS. |
Source: Maleki-Hajiagha, Arezoo, et al. “Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome – a randomized placebo-controlled clinical trial.” Read article here.
